Sobi and Savient Pharmaceuticals Announce Co-Promotion Agreement for KineretA (anakinra) in the U.S.

Home › Sobi and Savient Pharmaceuticals Announce Co-Promotion Agreement for KineretA (anakinra) in the U.S.

CONTACT: Swedish Orphan Biovitrum AB Alan Raffensperger Chief Operating Officer +46 8 697 20 90 Savient Pharmaceuticals, Inc.

15.11	Bitcoin hacker sentenced to five years in prison
15.11	Europe's flying taxi dreams falter as cash runs short
14.11	UK must rebuild post-Brexit relations with EU, says Bank boss
14.11	Meta fined 798m over 'unfair' Facebook Marketplace
14.11	Meta fined 798m over 'unfair' Facebook Marketplace
14.11	Amazon launches Temu and Shein rival with 'crazy low' prices
14.11	Bid to soften farm tax change rejected by Treasury
14.11	Bid to soften farm tax change rejected by Treasury
Consumer Goods and Services »

je.st